Then, we applied MorphoITH to evaluate the effect of key driver gene mutations in ccRCC (BAP1/PBRM1/SETD2), demonstrating that morphological heterogeneity reflects genetic heterogeneity and can guide efficient sampling strategies. This evidence concerns the gene PBRM1 and nonpapillary renal cell carcinoma.